Media Center | Welcome to our Newsroom
Stay informed with the latest news, press releases and related articles of interest regarding GC Biotherapeutics and the Plasma Protein Industry.
CoVIg-19 PLASMA ALLIANCE BUILDS STRONG MOMENTUM THROUGH EXPANDED MEMBERSHIP AND CLINICAL TRIAL COLLABORATION
CoVIg-19 PLASMA ALLIANCE BUILDS STRONG MOMENTUM THROUGH EXPANDED MEMBERSHIP AND CLINICAL TRIAL COLLABORATION Osaka, JAPAN, and King of Prussia, PA, USA – 7 May, 2020 – The CoVIg-19 Plasma Alliance,
Clinical Immunology Society (CIS) accepts GC Mogam’s abstract for poster presentation at their national conference.
Clinical Immunology Society (CIS) accepts GC Mogam’s abstract for poster presentation at their national conference. April 2-5, 2020 The Clinical Immunology Society (CIS) educational committee approved GC Mogam’s abstract for
GC Pharma Launches Project to Develop COVID-19 Vaccine and Treatment in South Korea with support from the Korea Center for Disease Control
GC Pharma Launches Project to Develop COVID-19 Vaccine and Treatment in South Korea with support from the Korea Center for Disease Control GC Pharma announced on March 19 that it
GC Mogam supports and participates in Soleo Health National Sales Meeting in Austin, Texas.
GC Mogam supports and participates in Soleo Health National Sales Meeting in Austin, Texas. March 2-5, 2020 Soleo Health, an innovative national provider of complex specialty pharmacy and infusion services, invited GC Mogam
GCAM opens a new plasma collection center in Texas.
GCAM, the US based plasma collection division of GC Pharma, opens a new collection center in Texas. FULLERTON, CA, Jan 10, 2020 – GCAM, Inc., a US-based plasma collection company, announced
Vaxess and GC Pharma to Collaborate on Development of Highly Effective Influenza Vaccine Smart Release Patch
Vaxess and GC Pharma to Collaborate on Development of Highly Effective Influenza Vaccine Smart Release Patch Vaxess will have exclusive rights to commercialize the MIMIX Flu Smart Release Patch in